Preliminary Structure–Activity Relationship Study of the MMV Pathogen Box Compound MMV675968 Unveils Novel Inhibitors of ITrypanosoma brucei brucei/I

• Published in: Molecules (Basel, Switzerland) Switzerland), 2022-10, Vol.27 (19)
• Main Authors: Dize, Darline, Tata, Rolland Bantar, Keumoe, Rodrigue, Kouipou Toghueo, Rufin Marie, Tchatat, Mariscal Brice, Njanpa, Cyrille Ngansop, Tchuenguia, Vianey Claire, Yamthe, Lauve Tchokouaha, Fokou, Patrick Valere Tsouh, Laleu, Benoît, Duffy, James, Bishop, Ozlem Tastan, Boyom, Fabrice Fekam
• Format: Article
• Language: English
• Subjects: African trypanosomiasis; Analysis; Antimalarials; Diagnosis; Dosage and administration; Drug discovery; Drug therapy; Methods; Structure-activity relationships (Biochemistry)
• ISSN: 1420-3049; 1420-3049
• DOI: 10.3390/molecules27196574

New drugs are urgently needed for the treatment of human African trypanosomiasis (HAT). In line with our quest for novel inhibitors of trypanosomes, a small library of analogs of the antitrypanosomal hit (MMV675968) available at MMV as solid materials was screened for antitrypanosomal activity. In silico exploration of two potent antitrypanosomal structural analogs (7-MMV1578647 and 10-MMV1578445) as inhibitors of dihydrofolate reductase (DHFR) was achieved, together with elucidation of other antitrypanosomal modes of action. In addition, they were assessed in vitro for tentative inhibition of DHFR in a crude trypanosome extract. Their ADMET properties were also predicted using dedicated software. Overall, the two diaminoquinazoline analogs displayed approximately 40-fold and 60-fold more potency and selectivity in vitro than the parent hit, respectively (MMV1578445 (10): IC[sub.50] = 0.045 µM, SI = 1737; MMV1578467 (7): IC[sub.50] = 0.06 µM; SI = 412). Analogs 7 and 10 were also strong binders of the DHFR enzyme in silico, in all their accessible protonation states, and interacted with key DHFR ligand recognition residues Val32, Asp54, and Ile160. They also exhibited significant activity against trypanosome protein isolate. MMV1578445 (10) portrayed fast and irreversible trypanosome growth arrest between 4–72 h at IC[sub.99] . Analogs 7 and 10 induced in vitro ferric iron reduction and DNA fragmentation or apoptosis induction, respectively. The two potent analogs endowed with predicted suitable physicochemical and ADMET properties are good candidates for further deciphering their potential as starting points for new drug development for HAT.